Here’s what Neil Woodford has been buying and selling since the Brexit vote

How has the UK’s most renowned investor reacted to the referendum result? Here’s what Neil Woodford has been up to.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After more than a quarter of a century of phenomenal success running funds for grateful clients, Neil Woodford knows more than a thing or two about managing a portfolio through all manner of political upheavals, economic cycles and stock market ups and downs.

Before the Brexit vote

Woodford had a good deal to say in the run-up to the referendum, both on the macro outlook and the positioning of his portfolio.

In brief, his take was that a leave vote would lead to short-term uncertainty, but that the UK and the world face much bigger challenges than Brexit, including — but not limited to — weakening global growth, excessive debt, and deflation.

As far as the positioning of his portfolio was concerned, he said he was invested in businesses that he believes will deliver high-single-digit growth per annum “despite these significant macro headwinds.” He added that “these companies trade on valuations which do not reflect that capability” and that “the portfolio strategy will not change on a ‘remain’ or ‘leave’ vote”.

Buying the domestic sell-off

After the ‘leave’ vote Woodford and his team observed that: “The initial sell-off gave way to pronounced rotation, as investors fled from domestically exposed stocks to those with global revenues. This move was largely indiscriminate, at least regarding valuations, as many market participants appeared determined to make the switch at almost any cost”.

Woodford was keen to take advantage of “the ill-informed investor behaviour (essentially, panic!), that is a common characteristic of financial markets in a state of shock.” He didn’t go buying any and every UK-facing business that had taken a hammering — for example, banks continue to be shunned — but notably added to two existing holdings “at highly distressed share price levels”.

Insurer Legal & General (LSE: LGEN) and sub-prime lender Provident Financial (LSE: PFG) fell 30% and 25%, respectively, in the immediate aftermath of the Brexit vote. Woodford and his team reckoned that this was a result of investors simply ditching domestic cyclicals and financials “regardless of valuation or prospects” — and having spoken to the management of both companies since the referendum they have concluded that both businesses remain well-placed to deliver very attractive rates of sustainable dividend growth in the years ahead”.

The shares of the two companies have recovered somewhat but continue to look attractively-valued to my eye. L&G trades on a forward P/E of 9.7 with a dividend yield of 7.2%, while the scores on the doors for the less-cyclical Provident Financial are 15.4 and 4.9%.

Babcock International, Capita and New River Retail are among other UK-facing businesses Woodford has added to since the vote.

Strong risers

Woodford’s tobacco stocks and major pharmaceutical companies, such as AstraZeneca (LSE: AZN), GlaxoSmithKline (LSE: GSK), Roche and AbbVie, were strong risers: “Indeed, such was the extent of the share price appreciation in some of these businesses, that we reduced the portfolio’s exposure to them,” he said, with Roche and Reynolds American singled out for mention in this respect.

I note, though, that AstraZeneca and GlaxoSmithKline were still ranked at two and three in the Equity Income Fund at 30 June with weightings of 8.1% and 7.6%, respectively.

Again, I also see value in these two stocks, which have nice dividends and, I believe, bright long-term futures. AstraZeneca trades on a forward P/E of 15.8 with a 4.5% dividend yield, and Glaxo on 18.2 with a 4.9% yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »